Special AT‐rich sequence binding protein 1 promotes multidrug resistance in gastric cancer by regulation of Ezrin to alter subcellular localization of ATP‐binding cassette transporters
Cancer Science · 2023
DOI: 10.1111/cas.15693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Jiajun Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery I Section, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Matrix Attachment Region Binding Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Multidrug resistance is a primary factor in the poor response to chemotherapy and subsequent death in gastric cancer patients. However, the molecular mechanisms involved remain unclear. In this study, the high expression of special AT‐rich sequence binding protein 1 (SATB1) in gastric cancer was found to be associated with reduced sensitivity to various chemotherapy drugs. Our results demonstrate that SATB1 can promote chemotherapy resistance in gastric cancer in vitro and in vivo. SATB1 exerts its effect by enhancing the activity of multiple ATP‐binding cassette (ABC) transporters (P‐glycoprotein, multidrug resistance‐associated protein, and breast cancer resistance protein) in gastric cancer cell lines. We also found that SATB1 affects ABC transporters by altering the subcellular localization of the ABC transporter rather than its expression. Subsequently, we confirmed that Ezrin binds to various ABC transporters and affects their subcellular localization. In addition, we found that SATB1 can also bind to the Ezrin promoter and regulate its expression. In the present study, we elucidate the mechanism of SATB1‐mediated multidrug resistance in gastric cancer, providing a basis for SATB1 as a potential target for reversal of resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery I Section, Renmin Hospital of Wuhan University, Wuhan, China.
ORCID-Profile: Jiajun Luo, Yue Jiang, Qiang Tong
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
Zitieren
APA
Luo, J., Yuan, J., Yang, Y., Jiang, Y., Yan, J., & Tong, Q. (2023). Special AT‐rich sequence binding protein 1 promotes multidrug resistance in gastric cancer by regulation of Ezrin to alter subcellular localization of ATP‐binding cassette transporters. Cancer Science. https://doi.org/10.1111/cas.15693
Vancouver
Luo J, Yuan J, Yang Y, Jiang Y, Yan J, Tong Q. Special AT‐rich sequence binding protein 1 promotes multidrug resistance in gastric cancer by regulation of Ezrin to alter subcellular localization of ATP‐binding cassette transporters. Cancer Science. 2023. doi:10.1111/cas.15693
BibTeX
@article{Luo2023,
author = {Luo, Jiajun and Yuan, Jingwen and Yang, Yu and Jiang, Yue and Yan, Junfeng and Tong, Qiang},
title = {Special AT‐rich sequence binding protein 1 promotes multidrug resistance in gastric cancer by regulation of Ezrin to alter subcellular localization of ATP‐binding cassette transporters},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15693}
}
EUVIMED